One-of-a-kind magnetic separation for scalable bioprocessing
Wednesday, November 19, at 15:00 GMT | 16:00 CET | 10:00 EST | 07:00 PST
Monoclonal antibody (mAb) purification remains one of the most resource-intensive steps in bioprocessing, slowing timelines, driving up costs, and creating scalability challenges for researchers and manufacturers alike.
Join our upcoming webinar with Prof. Véronique Chotteau, AdBIOPRO and Nils Brechmann, MAGic Bioprocessing, to discover how magnetic bead technology is reshaping purification workflows. Explore a the first-of-its-kind, large-scale magnetic separation device, and how it can offer economic advantages, as well as improve efficiency.
This session is designed for researchers, bioprocess engineers, and industry professionals looking to expand their expertise in scalable, efficient, and future-ready purification methods.
Key learning objectives:
- Uncover key insights into magnetic based down streaming
- Learn how to improve process economics
- Explore a novel one-of-its-kind magnetic separation system for large scale processing
- Gain knowledge on how to process directly from crude cell broth
Who should attend?
- Designed for development and strategic decision-makers across small biotech to large pharma.
- R&D scientists, development managers, strategy leads, CTOs, and CSOs.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Professor Véronique Chotteau brings over 35 years of expertise in mammalian cell culture, including a decade in the biopharmaceutical industry. She is the Director of AdBIOPRO and leads the Cell Technology group at the Royal Institute of Technology in Stockholm, Sweden. Since 2008, her research has focused on cell-based biologics production, perfusion processing, modelling, and process analytical technology (PAT).
Nils Brechmann holds a PhD in Industrial Biotechnology from the Royal Institute of Technology (KTH) in Stockholm, Sweden. With experience across diverse commercial roles, he combines scientific expertise in antibody purification and magnetic separation with strong strategic insight. He is passionate about advancing biomanufacturing and translating complex science into real-world impact.
Moderator
